BioVentrix Overview

  • Founded

  • 2003

Founded
  • Status

  • Private

  • Employees

  • 37

Employees
  • Latest Deal Type

  • Series A

  • Latest Deal Amount

  • $48.5M

  • Investors

  • 9

BioVentrix General Information

Description

Developer of surgical equipment designed to improve and expand the treatment for congestive heart failure. The company's equipment improves cardiac function by restoring the size, volume, and resulting function of the left ventricle in heart failure patients caused by ischemic cardiomyopathy, providing physicians with innovative technology that corrects the anatomical damage created by CHF to slow the progression of this debilitating and fatal disease.

Contact Information

Website
bioventrix.com
Formerly Known As
CHF Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 12647 Alcosta Boulevard
  • Suite 400
  • San Ramon, CA 94583
  • United States
+1 (925) 000-0000

BioVentrix Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioVentrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC (Series A) 03-Apr-2023 $48.5M 00000 Completed Generating Revenue
16. Later Stage VC 05-Apr-2022 000 00000 Completed Generating Revenue
15. Later Stage VC 10-Jan-2022 00.000 00000 Completed Generating Revenue
14. Later Stage VC 25-Nov-2020 000.00 00000 Completed Generating Revenue
13. Debt - PPP 14-Apr-2020 00000 00000 Completed Generating Revenue
12. Later Stage VC (Series A1) 23-Jul-2019 000.00 00000 Completed Generating Revenue
11. Later Stage VC 30-Jun-2017 000.00 000.00 Completed Generating Revenue
10. Later Stage VC (Series A) 08-Dec-2015 0000 000.00 00000 Completed Generating Revenue
9. Later Stage VC 08-Jul-2014 $14.4M $57.7M Completed Generating Revenue
8. Later Stage VC 11-Jul-2013 $11M $43.2M Completed Generating Revenue
To view BioVentrix’s complete valuation and funding history, request access »

BioVentrix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.0 00.00 00 00.0 0.000
To view BioVentrix’s complete cap table history, request access »

BioVentrix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of surgical equipment designed to improve and expand the treatment for congestive heart failure. The company's
Surgical Devices
San Ramon, CA
37 As of 2023
00000
00000000000 00000

000000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
00000000 0000000
Clichy, France
00 As of 0000
0000
00.00 0000-00-00
0000000000 0 0000

000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
00000000 0000000
Waltham, MA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioVentrix Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corwave Venture Capital-Backed Clichy, France 00 0000 0000000000 0 0000
00000000 00000000 Formerly VC-backed Waltham, MA 000 00000 000000&0 00000
000000 0000000 000 Corporate Backed or Acquired Montreal, Canada 000 000000&0
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
00000000000 Venture Capital-Backed Marlborough, MA 00 00000 00000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

BioVentrix Patents

  • 178

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 16

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

BioVentrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220087715-A1 Pericardial inflation catheter and systems and methods employing same Pending 24-Sep-2020 00000000000 0
EP-3407802-A1 Percutaneous arterial access to position transmyocardial implant devices and methods Pending 29-Jan-2016 0000000000
EP-3407802-A4 Percutaneous arterial access to position transmyocardial implant devices and methods Pending 29-Jan-2016 0000000000 0
US-11478353-B2 Percutaneous arterial access to position trans-myocardial implant devices and methods Active 29-Jan-2016 0000000000 000
US-20170216032-A1 Percutaneous arterial access to position trans-myocardial implant devices and methods Active 29-Jan-2016 A61F2/2481
To view BioVentrix’s complete patent history, request access »

BioVentrix Executive Team (15)

Name Title Board Seat Contact Info
James Dillon Chief Executive Officer, President & Board Member
William Abbott Chief Financial Officer & Managing Director
Steven Chartier Chief Operating Officer
Thasee Pillay Consultant
Lon Annest MD Co-Founder, Vice President of Medical Affairs & Consultant
You’re viewing 5 of 15 executive team members. Get the full list »

BioVentrix Board Members (16)

Name Representing Role Since
Andrew Coats Self Board Member 000 0000
Andrew Hinson BioVentrix Board Member 000 0000
Bihua Chen Cormorant Asset Management Board Member 000 0000
David Richmond BioVentrix Board Member 000 0000
George Fazio Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

BioVentrix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioVentrix Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andera Partners PE/Buyout Minority 000 0000 000000 0
Cormorant Asset Management Hedge Fund Minority 000 0000 000000 0
Squarepoint Capital Asset Manager Minority 000 0000 000000 0
Don Douglas Angel (individual) Minority 000 0000 000000 0
Psilos Group Managers Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

BioVentrix Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 27-Jan-2022 0000000000 Therapeutic Devices 00000 000
To view BioVentrix’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

BioVentrix Subsidiaries (1)

Company Name Industry Location Founded
000000000 Therapeutic Devices San Ramon, CA 0000
To view BioVentrix’s complete subsidiaries history, request access »